Organto Foods (OGO) Planet MicroCap Showcase: Toronto 2026 summary

Business model and markets

• Integrated farm-to-shelf platform connects growers, including smallholders, with retailers; product ownership, cold chain, customs, traceability and certifications managed through delivery.

• European operations span 16 countries and serve about 20 major retailers, including leading retailers in Germany, France, Austria and Denmark.

• Organic foods are projected to grow over 10% in the U.S. and Europe over the next four to five years; fair-trade sourcing also addresses consumer interest in food origins and worker treatment.

• The capital-efficient model uses grower and supply-chain partners without owning all farms or retail stores; operations include three European offices and a global shipping network.

Portfolio and positioning

• Core products include organic and fair-trade bananas, ginger, mango and blueberries; bananas and mangoes are the largest categories, while ginger is growing rapidly.

• Portfolio was streamlined after the 2024 repositioning, removing products that did not generate sufficient value; avocado remains available but is de-emphasized amid tougher margins.

• A new product is planned for Q4 2026, with additions to the portfolio expected to remain selective; organic and fair-trade bananas include 56 retailer-specific SKUs.

Results and financial position

• H1 sales were $53.3m, up 73%; margins increased 108%, and cash overhead costs continued to decline as a percentage of sales.

• EBITDA was positive in the quarter at 500 versus about 200 negative in the prior-year quarter; gross margins grew faster than sales amid volatile geopolitical and input-cost conditions.

• Revenue was $14m in 2023, $21m in 2024 and $61m in 2025; H1 2026 sales of $53.3m put the business on a trajectory above $100m for the year.

• Management described a $130m-$140m revenue range as a non-guidance outlook, conditional on no strategic changes; Q3 results were expected within two to three weeks of the presentation.

• Balance sheet had cash, positive working capital and equity, and no long-term debt; Rabobank operating line expanded from EUR 4m to EUR 7m in H1.